Hasbro Children's Hospital
Online Newsroom

Cindy Schwartz,MD

Cindy Schwartz, MD, is the director of pediatric hematology/oncology at Hasbro Children's Hospital in Providence, Rhode Island. She is an expert on the long-term effects of childhood cancer therapy on cardiac and reproductive function and on issues of cancer survivorship for adolescents, including quality of life. She has developed programs specifically for long-term cancer survivors at Johns Hopkins University School of Medicine (JHM) as well as the University of Rochester.

Schwartz's research interests include investigating the barriers to finding a cure for osteosarcoma and identifying new approaches to pediatric Hodgkin disease. As chair of the Hodgkin Disease Committee for the Children's Oncology Group, Schwartz has led the development of response-based and biologically targeted treatments for Hodgkin disease.

In addition to her appointment at the hospital, Schwartz is a professor of pediatrics at Brown Medical School. Previously, Schwartz was the associate director of clinical programs and clinical research in pediatric oncology at JHM and director of the Hopkins Long Term Program for childhood cancer survivors. She was also an associate professor of oncology and pediatrics at the university. Before joining JHM, Schwartz was the clinical director and acting division director for pediatric hematology/oncology and associate professor of pediatrics at the University of Rochester.

She also serves on various advisory committees for the National Cancer Institute, is the chair of the Data Safety Monitoring Board of Novel Approaches to Neuroblastoma Therapy (NANT), and is on the Scientific Advisory Board for the Childhood Cancer Survivor Study. Schwartz earned an undergraduate degree from Yale University and a medical degree from Brown Medical School. She completed her residency in pediatrics and fellowship in pediatric hematology/oncology at Johns Hopkins University School of Medicine. She is board certified in both pediatrics and pediatric hematology-oncology.